OrganOx Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK

Contributed by: Business Wire

Tags

Science
Biotechnology
Research
Surgery
Health
Medical Devices
Health Technology
Other Health
Headquarters in Oxford

More Like This

Appointment of Stephen M. Deitsch as new Chief Financial Officer

OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting

PR Newswire associated0

Bridge to Life Ltd. Achieves Global Milestone Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart™ System

PR Newswire associated0

Bridge to Life Achieves ISO 13485:2016 Certification, Reinforcing Commitment to Quality and Safety in Hypothermic Oxygenated Perfusion and Cold Flush Organ Preservation Solutions

PR Newswire associated0

Portuguese Transplant Center Analysis of First 100 Cases of Hypothermic Oxygenated PErfusion (HOPE) in Liver Transplantation Demonstrates Increased Use of Marginal Grafts, Making More Livers Available for Transplantation

PR Newswire associated0

Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability

PR Newswire associated0

Bridge to Life and ULS Coimbra Announce Collaboration to Enhance Preservation of Livers Awaiting Transplantation

PR Newswire associated0

Oxehealth Granted Regulatory Clearances for Mental Health Sleep Monitoring